Verici Dx plc (AIM:VRCI)
London · Delayed Price · Currency is GBP · Price in GBX 0.4000
+0.0250 (6.67%)
Jun 17, 2026, 3:37 PM GMT
Verici Dx Employees
Verici Dx had 15 employees as of June 30, 2025. The number of employees decreased by 3 or -16.67% since the number was reported on December 31, 2024.
Employees
15
Change
-3
Growth
-16.67%
Revenue / Employee
93.09K GBP
Profits / Employee
-370.59K GBP
Market Cap
5.68M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 15 | -3 | -16.67% |
| Dec 31, 2024 | 18 | 4 | 28.57% |
| Dec 31, 2023 | 14 | -1 | -6.67% |
| Dec 31, 2022 | 15 | 5 | 50.00% |
| Dec 31, 2021 | 10 | 2 | 25.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 96,100 |
| GSK plc | 66,841 |
| Haleon | 24,535 |
| Smith & Nephew | 16,988 |
| GENinCode | 45 |
| Proteome Sciences | 32 |
| OptiBiotix Health | 9 |
| Theracryf | 9 |
Verici Dx News
- 4 weeks ago - CORRECTING and REPLACING Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients - Business Wire
- 4 weeks ago - Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients - Business Wire
- 2 months ago - Verici Dx Earnings release: Q1 2026 - Filings
- 4 months ago - Verici Dx Earnings release: H2 2025 - Filings
- 9 months ago - Verici Dx Earnings Call Transcript: H1 2025 - Transcripts
- 9 months ago - Verici Dx Quarterly report: H1 2025 - Filings
- 9 months ago - Verici Dx Slides: H1 2025 - Filings
- 1 year ago - Verici Dx Annual report: H2 2024 - Filings